AMGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 308.4 USD | -0.55% |
|
+3.00% | +7.09% |
| 05-13 | Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating | MT |
| 05-09 | ANALYST RECOMMENDATIONS : UBER, Luluemon, Airbnb, Progressive... |  |
ETFs positioned on Amgen Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.73% | 85 M€ | +11.59% | - | |
| 0.71% | 330 M€ | -.--% | ||
| 0.67% | 1,448 M€ | -.--% | - | |
| 0.67% | 219 M€ | +17.17% | - | |
| 0.67% | 2,383 M€ | +12.58% | ||
| 0.66% | 2 M€ | +14.69% | - | |
| 0.66% | 8 M€ | +5.48% | - | |
| 0.65% | 253 M€ | +8.06% | ||
| 0.61% | 9 M€ | +8.59% | ||
| 0.58% | 2 M€ | +21.73% | - | |
| 0.57% | 368 M€ | +18.65% | - | |
| 0.56% | 655 M€ | -.--% | - | |
| 0.56% | 1,174 M€ | +23.54% | ||
| 0.56% | 273 M€ | -.--% | ||
| 0.56% | 5 M€ | -.--% | - | |
| 0.56% | 1,487 M€ | +7.21% | - | |
| 0.55% | 104 M€ | +8.99% | ||
| 0.52% | 92 M€ | +0.06% | - | |
| 0.52% | 7 M€ | +6.22% | - | |
| 0.50% | 26 M€ | +19.43% | - | |
| 0.49% | 1,848 M€ | +18.39% | ||
| 0.49% | 559 M€ | +14.30% | ||
| 0.49% | 727 M€ | +8.46% | ||
| 0.48% | 375 M€ | +7.91% | ||
| 0.48% | 276 M€ | +11.40% | - | |
| 0.46% | 264 M€ | -.--% | - | |
| 0.46% | 187 M€ | +9.15% | - | |
| 0.46% | 477 M€ | +11.46% | ||
| 0.45% | 25 M€ | +4.06% | - | |
| 0.45% | 1,006 M€ | -.--% | ||
| 0.45% | 414 M€ | +11.90% | - | |
| 0.44% | 6 M€ | +17.98% | - | |
| 0.44% | 121 M€ | +6.79% | - | |
| 0.42% | 17 M€ | +4.26% | - |
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.09% | 166B | |
| +29.98% | 684B | |
| +30.34% | 568B | |
| -3.52% | 361B | |
| +18.59% | 329B | |
| +4.07% | 284B | |
| +16.21% | 240B | |
| +9.66% | 208B | |
| -6.83% | 200B | |
| -1.22% | 159B |
- Stock Market
- Equities
- AMGN Stock
- Funds and ETFs Amgen Inc.
